TY - JOUR AU - Khan, S. A. AU - Taylor-Robinson, S. D. AU - Toledano, M. B. AU - Beck, A. AU - Elliott, P. AU - Thomas, H. C. PY - 2002 DA - 2002// TI - Changing international trends in mortality rates for liver, biliary and pancreatic tumours JO - J Hepatol VL - 37 UR - https://doi.org/10.1016/S0168-8278(02)00297-0 DO - 10.1016/S0168-8278(02)00297-0 ID - Khan2002 ER - TY - JOUR AU - Saha, S. K. AU - Zhu, A. X. AU - Fuchs, C. S. AU - Brooks, G. A. PY - 2016 DA - 2016// TI - Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise JO - Oncologist VL - 21 UR - https://doi.org/10.1634/theoncologist.2015-0446 DO - 10.1634/theoncologist.2015-0446 ID - Saha2016 ER - TY - JOUR AU - Bridgewater, J. AU - Galle, P. R. AU - Khan, S. A. PY - 2014 DA - 2014// TI - Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma JO - J Hepatol VL - 60 UR - https://doi.org/10.1016/j.jhep.2014.01.021 DO - 10.1016/j.jhep.2014.01.021 ID - Bridgewater2014 ER - TY - JOUR AU - Khan, S. A. AU - Davidson, B. R. AU - Goldin, R. PY - 2002 DA - 2002// TI - Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document JO - Gut VL - 51 ID - Khan2002 ER - TY - JOUR PY - 2015 DA - 2015// TI - Gallbladder carcinoma: prognostic factors and therapeutic options JO - World J Gastroenterol VL - 21 UR - https://doi.org/10.3748/wjg.v21.i43.12211 DO - 10.3748/wjg.v21.i43.12211 ID - ref5 ER - TY - JOUR AU - Takada, T. AU - Kato, H. AU - Matsushiro, T. AU - Nimura, Y. AU - Nagakawa, T. AU - Nakayama, T. PY - 1994 DA - 1994// TI - Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas JO - Oncology VL - 51 UR - https://doi.org/10.1159/000227373 DO - 10.1159/000227373 ID - Takada1994 ER - TY - JOUR AU - Neoptolemos, J. P. AU - Moore, M. J. AU - Cox, T. F. PY - 2012 DA - 2012// TI - Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial JO - JAMA VL - 308 UR - https://doi.org/10.1001/jama.2012.7352 DO - 10.1001/jama.2012.7352 ID - Neoptolemos2012 ER - TY - JOUR AU - Kwon, J. AU - Kim, B. H. AU - Kim, K. AU - Chie, E. K. AU - Ha, S. W. PY - 2015 DA - 2015// TI - Survival benefit of adjuvant Chemoradiotherapy in patients with ampulla of Vater cancer: a systematic review and meta-analysis JO - Ann Surg VL - 262 UR - https://doi.org/10.1097/SLA.0000000000001182 DO - 10.1097/SLA.0000000000001182 ID - Kwon2015 ER - TY - JOUR AU - Horgan, A. M. AU - Amir, E. AU - Walter, T. AU - Knox, J. J. PY - 2012 DA - 2012// TI - Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.40.5381 DO - 10.1200/JCO.2011.40.5381 ID - Horgan2012 ER - TY - JOUR AU - McNamara, M. G. AU - Walter, T. AU - Horgan, A. M. PY - 2015 DA - 2015// TI - Outcome of adjuvant therapy in biliary tract cancers JO - Am J Clin Oncol VL - 38 UR - https://doi.org/10.1097/COC.0b013e31829e19fb DO - 10.1097/COC.0b013e31829e19fb ID - McNamara2015 ER - TY - JOUR AU - Burris, H. A. AU - Moore, M. J. AU - Andersen, J. PY - 1997 DA - 1997// TI - Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 15 UR - https://doi.org/10.1200/JCO.1997.15.6.2403 DO - 10.1200/JCO.1997.15.6.2403 ID - Burris1997 ER - TY - JOUR AU - Oettle, H. AU - Neuhaus, P. AU - Hochhaus, A. PY - 2013 DA - 2013// TI - Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial JO - JAMA VL - 310 UR - https://doi.org/10.1001/jama.2013.279201 DO - 10.1001/jama.2013.279201 ID - Oettle2013 ER - TY - JOUR AU - Verderame, F. AU - Mandina, P. AU - Abruzzo, F. AU - Scarpulla, M. AU - Di Leo, R. PY - 2000 DA - 2000// TI - Biliary tract cancer: our experience with gemcitabine treatment JO - Anti-Cancer Drugs VL - 11 UR - https://doi.org/10.1097/00001813-200010000-00006 DO - 10.1097/00001813-200010000-00006 ID - Verderame2000 ER - TY - JOUR AU - Kubicka, S. AU - Rudolph, K. L. AU - Tietze, M. K. AU - Lorenz, M. AU - Manns, M. AU - Phase, I. I. PY - 2001 DA - 2001// TI - Study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas JO - Hepato-Gastroenterology VL - 48 ID - Kubicka2001 ER - TY - JOUR AU - Kiba, T. AU - Nishimura, T. AU - Matsumoto, S. PY - 2006 DA - 2006// TI - Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature JO - Oncology VL - 70 UR - https://doi.org/10.1159/000098109 DO - 10.1159/000098109 ID - Kiba2006 ER - TY - JOUR AU - Valle, J. AU - Wasan, H. AU - Palmer, D. H. PY - 2010 DA - 2010// TI - Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0908721 DO - 10.1056/NEJMoa0908721 ID - Valle2010 ER - TY - JOUR AU - Schweitzer, N. AU - Weber, T. AU - Kirstein, M. M. PY - 2017 DA - 2017// TI - The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis JO - J Cancer Res Clin Oncol VL - 143 UR - https://doi.org/10.1007/s00432-017-2392-8 DO - 10.1007/s00432-017-2392-8 ID - Schweitzer2017 ER - TY - JOUR AU - Kim, Y. S. AU - SY, O. AU - Go, S. I. PY - 2017 DA - 2017// TI - The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas JO - Cancer Chemother Pharmacol VL - 79 UR - https://doi.org/10.1007/s00280-016-3206-4 DO - 10.1007/s00280-016-3206-4 ID - Kim2017 ER - TY - JOUR AU - Dover, L. L. AU - Oster, R. A. AU - McDonald, A. M. AU - DuBay, D. A. AU - Wang, T. N. AU - Jacob, R. PY - 2016 DA - 2016// TI - Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma JO - HPB (Oxford) VL - 18 UR - https://doi.org/10.1016/j.hpb.2016.07.008 DO - 10.1016/j.hpb.2016.07.008 ID - Dover2016 ER - TY - JOUR AU - Mizuno, T. AU - Ebata, T. AU - Yokoyama, Y. PY - 2017 DA - 2017// TI - Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis JO - Surg Today VL - 47 UR - https://doi.org/10.1007/s00595-016-1354-0 DO - 10.1007/s00595-016-1354-0 ID - Mizuno2017 ER - TY - JOUR AU - Murakami, Y. AU - Uemura, K. AU - Sudo, T. PY - 2009 DA - 2009// TI - Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma JO - J Gastrointest Surg VL - 13 UR - https://doi.org/10.1007/s11605-009-0900-0 DO - 10.1007/s11605-009-0900-0 ID - Murakami2009 ER - TY - JOUR AU - Valle, J. W. AU - Borbath, I. AU - Khan, S. A. AU - Huguet, F. AU - Gruenberger, T. AU - Arnold, D. PY - 2016 DA - 2016// TI - Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw324 DO - 10.1093/annonc/mdw324 ID - Valle2016 ER - TY - JOUR AU - Kainuma, O. AU - Miura, F. AU - Furukawa, D. PY - 2015 DA - 2015// TI - Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer JO - J Hepatobiliary Pancreat Sci VL - 22 UR - https://doi.org/10.1002/jhbp.283 DO - 10.1002/jhbp.283 ID - Kainuma2015 ER - TY - JOUR AU - Toyoda, M. AU - Ajiki, T. AU - Fujiwara, Y. PY - 2014 DA - 2014// TI - Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) JO - Cancer Chemother Pharmacol VL - 73 UR - https://doi.org/10.1007/s00280-014-2431-y DO - 10.1007/s00280-014-2431-y ID - Toyoda2014 ER - TY - JOUR AU - Cho, M. AU - Wang-Gillam, A. AU - Myerson, R. PY - 2015 DA - 2015// TI - A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma JO - HPB (Oxford) VL - 17 UR - https://doi.org/10.1111/hpb.12413 DO - 10.1111/hpb.12413 ID - Cho2015 ER - TY - JOUR AU - Stein, A. AU - Arnold, D. AU - Bridgewater, J. PY - 2015 DA - 2015// TI - Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1498-0 DO - 10.1186/s12885-015-1498-0 ID - Stein2015 ER - TY - JOUR AU - Ramirez-Merino, N. AU - Aix, S. P. AU - Cortes-Funes, H. PY - 2013 DA - 2013// TI - Chemotherapy for cholangiocarcinoma: an update JO - World journal of gastrointestinal oncology VL - 5 UR - https://doi.org/10.4251/wjgo.v5.i7.171 DO - 10.4251/wjgo.v5.i7.171 ID - Ramirez-Merino2013 ER - TY - STD TI - Edeline J, Bonnetain F, Phelip J, et al. Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial. J Clin Oncol. 2017;35(suppl 4S; abstr 225) ID - ref28 ER - TY - STD TI - BILCAP. A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer. J Clin Oncol. 2011;29(suppl; abstr 4125):4125. ID - ref29 ER - TY - STD TI - Primrose J, Fox R, Palmer D, et al. Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study. J Clin Oncol. 2017;35(suppl; abstr 4006):4006. ID - ref30 ER -